BHC (Bausch Health) Retained Earnings: $-11,090 Mil (As of Mar. 2026)


BHC Bausch Health Companies Inc BHC
58 GF Score
Price $4.81
GF Value $7.91
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Bausch Health Retained Earnings?

Bausch Health BHC -1.84% 58 Retained Earnings is $-11,090 Mil as of Mar. 2026. GuruFocus rates BHC with a GF Score™ of 58/100 and a GF Value™ of $7.91 (Possible Value Trap). The stock has 3 warning signs investors should review.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Bausch Health's retained earnings for the quarter that ended in Mar. 2026 was $-11,090 Mil.

Bausch Health's quarterly retained earnings declined from Sep. 2025 ($-9,555 Mil) to Dec. 2025 ($-9,667 Mil) and declined from Dec. 2025 ($-9,667 Mil) to Mar. 2026 ($-11,090 Mil).

Bausch Health's annual retained earnings declined from Dec. 2023 ($-9,778 Mil) to Dec. 2024 ($-9,824 Mil) but then increased from Dec. 2024 ($-9,824 Mil) to Dec. 2025 ($-9,667 Mil).


Bausch Health  (NYSE:BHC) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Bausch Health Retained Earnings Historical Data

* Premium members only.

The historical data trend for Bausch Health's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bausch Health Retained Earnings Chart

Bausch Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8,961.00 -9,186.00 -9,778.00 -9,824.00 -9,667.00

Bausch Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9,882.00 -9,734.00 -9,555.00 -9,667.00 -11,090.00
BHC
58GF Score
Bausch Health Companies Inc BHC
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bausch Health Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of $-11,090 Mil mean?
Bausch Health (BHC) has a Retained Earnings of $-11,090 Mil as of Mar. 2026. Retained earnings is the amount of net income not issued to shareholders. View historical data on Bausch Health and its competitors.
Is Bausch Health's Retained Earnings too high?
Bausch Health's current Retained Earnings is $-11,090 Mil. Overall, Bausch Health has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bausch Health's Retained Earnings compare to ZTS and UTHR?
Bausch Health's Retained Earnings of $-11,090 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Drug Manufacturers company?
A good Retained Earnings depends on the Drug Manufacturers industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on Bausch Health and its competitors. Bausch Health's current Retained Earnings is $-11,090 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bausch Health stock overvalued right now?
Based on GuruFocus' analysis, Bausch Health (BHC) is currently considered Possible Value Trap. The stock's GF Value™ is $7.91, compared to a current price of $4.81 — trading 39.2% below its estimated fair value. The current Retained Earnings is $-11,090 Mil. Bausch Health's overall GF Score™ is 58/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For Bausch Health (BHC), the current Retained Earnings is $-11,090 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bausch Health (BHC) Overvalued in 2026?

Based on GuruFocus' analysis, Bausch Health stock appears to be undervalued. The current stock price of $4.81 is trading 39.2% below its estimated GF Value™ of $7.91. GuruFocus considers Bausch Health to be Possible Value Trap.

Key valuation signals for BHC:

  • Retained Earnings: $-11,090 Mil
  • GF Value™: $7.91 vs. price of $4.81 (39.2% below fair value)
  • GF Score™: 58/100 with 3 warning signs

No single metric tells the full story. See the BHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bausch Health Business Description

Address 2150 St Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
58GF Score

Get the complete analysis for BHC

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.81
Price
$7.91
GF Value